↓ Skip to main content

Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-κB pathway

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, June 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#2 of 1,937)
  • High Attention Score compared to outputs of the same age (99th percentile)

Mentioned by

twitter
631 tweeters
facebook
1 Facebook page
reddit
3 Redditors
video
1 video uploader

Citations

dimensions_citation
42 Dimensions

Readers on

mendeley
53 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-κB pathway
Published in
Journal of Experimental & Clinical Cancer Research, June 2019
DOI 10.1186/s13046-019-1251-7
Pubmed ID
Authors

Lu Jiang, Pan Wang, Ying-Jian Sun, Yi-Jun Wu

Twitter Demographics

The data shown below were collected from the profiles of 631 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 53 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 53 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 17%
Researcher 6 11%
Student > Bachelor 5 9%
Student > Postgraduate 4 8%
Student > Master 4 8%
Other 10 19%
Unknown 15 28%
Readers by discipline Count As %
Medicine and Dentistry 9 17%
Biochemistry, Genetics and Molecular Biology 5 9%
Veterinary Science and Veterinary Medicine 4 8%
Pharmacology, Toxicology and Pharmaceutical Science 4 8%
Nursing and Health Professions 3 6%
Other 9 17%
Unknown 19 36%

Attention Score in Context

This research output has an Altmetric Attention Score of 473. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 August 2022.
All research outputs
#42,043
of 21,795,229 outputs
Outputs from Journal of Experimental & Clinical Cancer Research
#2
of 1,937 outputs
Outputs of similar age
#789
of 285,609 outputs
Outputs of similar age from Journal of Experimental & Clinical Cancer Research
#1
of 1 outputs
Altmetric has tracked 21,795,229 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,937 research outputs from this source. They receive a mean Attention Score of 3.7. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 285,609 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them